GLP-1 Prescribing Decisions: Compounded or Brand-Name?

Published on 14 Nov 2024 on Medscape

The decision to prescribe a compounded or brand-name glucagon-like peptide 1 (GLP-1) medication for...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the Jim Cramer’s Lightning Round: 8 Stocks to Watch. In this artic...

Insider Monkey · via Yahoo Finance 20 Nov 2024

Rank Eli Lilly has a Zacks Rank #3 (Hold) currently. You can see the complete list of today’s Zac...

Zacks · via Yahoo Finance 19 Nov 2024

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third...

Insider Monkey · via Yahoo Finance 19 Nov 2024

A federal judge has ruled Eli Lilly and Company did not break the law when it fired an employee w...

WISH-TV Indianapolis 18 Nov 2024

Enthusiasm for Club holding Eli Lilly needs to be tempered — at least for now — as Wall Street...

CNBC 15 Nov 2024

The decision to prescribe a compounded or brand-name glucagon-like peptide 1 (GLP-1) medication f...

Medscape 14 Nov 2024

This segment is sponsored by Boehringer Ingelheim and Eli Lilly and Company. What do hip-hop and...

KOKH FOX 25 14 Nov 2024

Eli Lilly and Company (LLY, Financials) said tirzepatide drastically reduced the risk of type 2...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

Primary care clinicians are frequently asked to conduct evaluations for patients scheduled for...

Medscape 13 Nov 2024

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Eli Lilly and Company, Novo Nordisk A/S,...

Investing.com 13 Nov 2024